Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St Jude CE marks Eon neurostimulators for new indication: chronic migraine

This article was originally published in Clinica

Executive Summary

St Jude Medical's Eon family of neurostimulators are now available to patients in the EU with chronic intractable migraine, after the company CE marked the devices for this new indication. The products have already been approved worldwide to treat chronic pain of the trunk and limbs, including in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099411

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel